Sun Pharmaceutical Industries Inc. is recalling 50,868 bottles of Metformin HCl Extended-Release Tablets (500 mg) because the tablets may contain a foreign substance identified as activated carbon. This prescription medication is used to control blood sugar levels in patients with type 2 diabetes. Consumers should check their 500-count bottles for the specific lot numbers and expiration dates included in this recall. Because this is a prescription medication, you should consult with your healthcare provider or pharmacist for guidance before stopping the medication or seeking a replacement.
The presence of activated carbon, a foreign substance not intended to be in the medication, can affect the purity and quality of the tablets. While activated carbon is sometimes used medically, its unauthorized presence in this medication poses a moderate risk of unintended side effects or reduced treatment efficacy.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.